Public information presented according to the provisions of Directive 2001/18/EC
File:
Trial reference:
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy
Doc type: